UNSPSC 85682040: Replacement of nasal bone with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of nasal bone with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NRB4KZ

UNSPSC 85682040 Replacement of nasal bone with nonautologous tissue substitute, percutaneous endoscopic approach (Commodity) does not align with state and local procurement activity in the provided source material. The code's scope names a specific surgical procedure involving nasal bone replacement, yet all six recent state and local opportunities tagged under this code address occupational medical surveillance, independent disability medical evaluations, surgical benefit carve-outs for government employees, pharmacy benefit management, temporary health professional staffing, and specialty medical services for youth in custody — none of which involve nasal bone procedures or tissue substitutes. The mismatch suggests either a cataloging error in the source or that the code has been applied incorrectly to opportunities in the health services administration, benefits management, and occupational health domains rather than orthopedic or otolaryngologic surgical procedures.

The opportunities actually being solicited span multiple issuing bodies including municipal retirement systems (City of Phoenix), city employees (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county juvenile justice (Harris County), county human resources (Collier County), and regional health systems (County of Santa Clara), with geographic activity in Arizona, California, Florida, and Washington. Without verifiable opportunities that match the code's stated procedure scope, pursue or skip decisions should be based on whether your firm has general health services capabilities rather than on genuine market signals under this particular code.